Curatis Holding AG Stock: price and insider trades · Switzerland

Curatis Holding AG is a Health Care company. Its directors and officers file their transactions with SIX SER. 2 insiders have disclosed 13 filings since 18 October 2025.

Both sides are active: 3 purchases worth €247k and 10 sales worth €669k, from 1 insider and 2 insiders respectively. On balance, insiders were net sellers of €422k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Biggest ticket of the year: €262k, sold and made public on 27 May 2026 (0.22% of market cap). The buyers include 1 senior executive.

For context, the typical company on the same exchange (median of 178 companies) published 9 filings over the same period, against 13 filings here. Our records for Curatis Holding AG go back to 2023, with 10 purchases and 19 sales on the open market in total.

The latest purchase dates back some time: it was published 282 days ago, on 9 January 2026. Half of the filings or more reach the SIX SER feed on the day of the trade. The shorter that gap, the sooner other investors can see what insiders have done. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.

For comparison within the same sector, see the insider buying recorded at Anixa Biosciences Inc and Vivos Inc. This summary is built from SIX SER disclosures alone and does not predict where the share price will go.